Table of Content

"1    INTRODUCTION    28
1.1    OBJECTIVES OF THE STUDY    28
1.2    MARKET DEFINITION    28
1.2.1    INCLUSIONS & EXCLUSIONS    28
1.3    MARKET SCOPE    29
FIGURE 1    EXOSOME RESEARCH MARKET    29
1.3.1    YEARS CONSIDERED FOR THE STUDY    29
1.4    CURRENCY    30
1.5    LIMITATIONS    30
1.6    STAKEHOLDERS    30
1.7    SUMMARY OF CHANGES    31
2    RESEARCH METHODOLOGY    32
2.1    RESEARCH DATA    32
FIGURE 2    RESEARCH DESIGN    32
2.1.1    SECONDARY DATA    33
2.1.2    PRIMARY DATA    34
FIGURE 3    EXOSOME RESEARCH MARKET: BREAKDOWN OF PRIMARIES    34
2.2    MARKET SIZE ESTIMATION    35
FIGURE 4    MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF EXOSOME RESEARCH IN THE MARKET    35
FIGURE 5    MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020    35
FIGURE 6    AVERAGE MARKET SIZE ESTIMATION, 2020    36
2.3    GROWTH RATE ASSUMPTIONS/GROWTH FORECAST    37
FIGURE 7    EXOSOME RESEARCH MARKET: CAGR PROJECTIONS, 2021–2026    38
FIGURE 8    EXOSOME RESEARCH MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS CHALLENGES, AND OPPORTUNITIES    38
FIGURE 9    MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH    39
2.4    MARKET BREAKDOWN AND DATA TRIANGULATION    40
FIGURE 10    DATA TRIANGULATION METHODOLOGY    40
2.5    INSIGHTS FROM PRIMARIES    41
FIGURE 11    MARKET VALIDATION FROM PRIMARY EXPERTS    41
2.6    RESEARCH ASSUMPTIONS    41
2.6.1    COVID-19 SPECIFIC ASSUMPTIONS    42
2.7    RISK ANALYSIS    42
3    EXECUTIVE SUMMARY    43
FIGURE 12    EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION)    43
FIGURE 13    EXOSOME RESEARCH MARKET, BY INDICATION,
2021 VS. 2026 (USD MILLION)    44
FIGURE 14    EXOSOME RESEARCH MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)    44
FIGURE 15    EXOSOME RESEARCH MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)    45
FIGURE 16    GEOGRAPHICAL SNAPSHOT: EXOSOME RESEARCH MARKET    46
4    PREMIUM INSIGHTS    47
4.1    EXOSOME RESEARCH MARKET OVERVIEW    47
FIGURE 17    RISING INVESTMENTS IN THE PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH    47
4.2    NORTH AMERICA: EXOSOME RESEARCH MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)    48
FIGURE 18    KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF
NORTH AMERICAN EXOSOME RESEARCH MARKET IN 2020    48
4.3    EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021 VS. 2026 (USD MILLION)    48
FIGURE 19    LUNG CANCER SEGMENT TO DOMINATE THE MARKET IN 2026    48
5    MARKET OVERVIEW    49
5.1    INTRODUCTION    49
5.2    MARKET DYNAMICS    49
FIGURE 20    EXOSOME RESEARCH MARKET: DRIVERS, OPPORTUNITIES, RESTRAINTS, AND CHALLENGES    49
TABLE 1    EXOSOME RESEARCH MARKET: IMPACT ANALYSIS    50
5.2.1    DRIVERS    50
5.2.1.1    Increasing investments in pharmaceutical R&D and life science research    50
5.2.1.2    Rising cancer prevalence    51
TABLE 2    GLOBAL CANCER INCIDENCE, 2020 VS. 2025    51
5.2.1.3    Increasing interest in exosome-based procedures    51
5.2.2    RESTRAINTS    52
5.2.2.1    Lack of skilled professionals    52
5.2.3    OPPORTUNITIES    53
5.2.3.1    Untapped emerging markets    53
5.2.3.2    Growing interest in exosome-based therapeutics    53
5.2.3.3    High demand for personalized medicine    54
5.2.4    CHALLENGE    54
5.2.4.1    Lack of gold standard protocols for development & production of exosomes    54
5.3    IMPACT OF COVID-19 OUTBREAK ON EXOSOME RESEARCH MARKET    55
TABLE 3    EXOSOME CONTRIBUTION IN COVID-19 CLINICAL RESEARCH    55
TABLE 4    ONGOING CLINICAL TRIALS FOR EXOSOME-BASED COVID-19 THERAPY    56
5.4    ECOSYSTEM AND VALUE CHAIN ANALYSIS    56
FIGURE 21    EXOSOME RESEARCH MARKET: ECOSYSTEM ANALYSIS    57
5.5    REGULATORY ANALYSIS    59
6    EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE    60
6.1    INTRODUCTION    61
TABLE 5    EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    61
6.2    KITS & REAGENTS    61
TABLE 6    EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION)    62
TABLE 7    NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    62
TABLE 8    EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    62
TABLE 9    ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    63
TABLE 10    EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    63
6.2.1    ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS    63
6.2.1.1    Rapid and easy-to-use kits and reagents have gained significant demand in the past few years in the market    63
TABLE 11    EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)    64
TABLE 12    NORTH AMERICA: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    64
TABLE 13    EUROPE: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    64
TABLE 14    ASIA PACIFIC: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    65
6.2.2    ANTIBODIES    65
6.2.2.1    High demand for exosome-based markers for disease detection is expected to propel the segment growth    65
TABLE 15    EXOSOME RESEARCH ANTIBODIES MARKET, BY REGION,
2019–2026 (USD MILLION)    65
TABLE 16    NORTH AMERICA: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    66
TABLE 17    EUROPE: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    66
TABLE 18    ASIA PACIFIC: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    66
6.2.3    OTHER KITS & REAGENTS    67
TABLE 19    OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION)    67
TABLE 20    NORTH AMERICA: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    67
TABLE 21    EUROPE: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    68
TABLE 22    ASIA PACIFIC: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    68
6.3    SERVICES    68
6.3.1    PLAYERS OFFER END-TO-END RESEARCH SERVICES FOR LABS    68
TABLE 23    EXOSOME RESEARCH SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION)    69
TABLE 24    NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    69
TABLE 25    EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    69
TABLE 26    ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    70
6.4    INSTRUMENTS    70
6.4.1    DEMAND FOR SCALABLE DEVELOPMENT OF EXOSOMES VIA HIGH THROUGHPUT SYSTEMS AUGMENTS THE SEGMENT GROWTH    70
TABLE 27    EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION)    71
TABLE 28    NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    71
TABLE 29    EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    71
TABLE 30    ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    72
7    EXOSOME RESEARCH MARKET, BY INDICATION    73
7.1    INTRODUCTION    74
TABLE 31    EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)    74
7.2    CANCER    74
TABLE 32    EXOSOME RESEARCH MARKET FOR CANCER, BY REGION,
2019–2026 (USD MILLION)    75
TABLE 33    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)    75
TABLE 34    EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY,
2019–2026 (USD MILLION)    75
TABLE 35    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)    76
TABLE 36    EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    76
7.2.1    LUNG CANCER    76
7.2.1.1    Increasing prevalence of lung cancer and technological advancements in instruments & assays for liquid biopsy to drive market growth    76
TABLE 37    EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY REGION,
2019–2026 (USD MILLION)    77
TABLE 38    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR LUNG CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    77
TABLE 39    EUROPE: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2019–2026 (USD MILLION)    77
TABLE 40    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR LUNG CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    78
7.2.2    BREAST CANCER    78
7.2.2.1    High prevalence and increasing awareness to drive the market for this segment    78
TABLE 41    EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY REGION,
2019–2026 (USD MILLION)    78
TABLE 42    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BREAST CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    79
TABLE 43    EUROPE: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2019–2026 (USD MILLION)    79
TABLE 44    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BREAST CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    79
7.2.3    PROSTATE CANCER    80
7.2.3.1    Liquid biopsy helps detect aggressive prostate cancer before surgery—a key factor driving market growth    80
TABLE 45    EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY REGION,
2019–2026 (USD MILLION)    80
TABLE 46    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    80
TABLE 47    EUROPE: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    81
TABLE 48    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    81
7.2.4    COLORECTAL CANCER    81
7.2.4.1    Increasing research activities and projects based on exosomes to drive the market for this segment    81
TABLE 49    EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2026 (USD MILLION)    82
TABLE 50    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2019–2026 (USD MILLION)    82
TABLE 51    EUROPE: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    82
TABLE 52    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)    83
7.2.5    OTHER CANCERS    83
TABLE 53    EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY REGION,
2019–2026 (USD MILLION)    83
TABLE 54    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER CANCERS,
BY COUNTRY, 2019–2026 (USD MILLION)    84
TABLE 55    EUROPE: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2019–2026 (USD MILLION)    84
TABLE 56    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER CANCERS,
BY COUNTRY, 2019–2026 (USD MILLION)    84
7.3    NEURODEGENERATIVE DISEASES    85
7.3.1    POTENTIAL OF SALIVARY EXOSOMAL CONTENT AS BIOMARKERS HAS OPENED AVENUES IN RESEARCH FOR NEURODEGENERATIVE DISEASES    85
TABLE 57    EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES,
BY REGION, 2019–2026 (USD MILLION)    85
TABLE 58    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    85
TABLE 59    EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    86
TABLE 60    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    86
7.4    CARDIOVASCULAR DISEASES    86
7.4.1    GROWING RESEARCH ON EXTRACELLULAR VESICLES FOR CVD TO PROPEL THE SEGMENT GROWTH    86
TABLE 61    EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES,
BY REGION, 2019–2026 (USD MILLION)    87
TABLE 62    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    87
TABLE 63    EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    87
TABLE 64    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    88
7.5    INFECTIOUS DISEASES    88
7.5.1    POTENTIAL USE OF EXOSOMES IN DEVELOPING NOVEL COVID-19 TREATMENT SOLUTIONS IS EXPECTED TO DRIVE THE MARKET    88
TABLE 65    EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019–2026 (USD MILLION)    89
TABLE 66    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)    89
TABLE 67    EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION)    89
TABLE 68    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION)    90
7.6    OTHER INDICATIONS    90
TABLE 69    EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION,
2019–2026 (USD MILLION)    90
TABLE 70    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    91
TABLE 71    EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)    91
TABLE 72    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)    91
8    EXOSOME RESEARCH MARKET, BY APPLICATION    92
8.1    INTRODUCTION    93
TABLE 73    EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    93
8.2    BIOMARKERS    93
8.2.1    BIOMARKERS FORM THE LARGEST APPLICATION SEGMENT    93
TABLE 74    EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION,
2019–2026 (USD MILLION)    94
TABLE 75    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS,
BY COUNTRY, 2019–2026 (USD MILLION)    94
TABLE 76    EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2019–2026 (USD MILLION)    94
TABLE 77    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS,
BY COUNTRY, 2019–2026 (USD MILLION)    95
8.3    VACCINE DEVELOPMENT    95
8.3.1    POTENTIAL OF EXOSOMES TO COMBAT BACTERIAL INFECTIONS DRIVING INTEREST IN VACCINE APPLICATIONS    95
TABLE 78    EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)    95
TABLE 79    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)    96
TABLE 80    EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION)    96
TABLE 81    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)    96
8.4    TISSUE REGENERATION    97
8.4.1    STUDIES CONDUCTED ON MOLECULAR PAYLOADS OF EXOSOMES TO ENHANCE TISSUE REGENERATION DRIVES MARKET GROWTH    97
TABLE 82    EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2019–2026 (USD MILLION)    97
TABLE 83    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION)    97
TABLE 84    EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION,
BY COUNTRY, 2019–2026 (USD MILLION)    98
TABLE 85    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION)    98
8.5    OTHER APPLICATIONS    98
TABLE 86    EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)    99
TABLE 87    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)    99
TABLE 88    EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)    99
TABLE 89    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)    100
9    EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE    101
9.1    INTRODUCTION    102
TABLE 90    EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE,
2019–2026 (USD MILLION)    102
9.2    STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES    102
9.2.1    INCREASED DEMAND FOR MSC-EXOSOMES IN THERAPEUTICS AUGMENTS THE SEGMENT GROWTH    102
9.3    DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING SERVICES    103
9.3.1    SIGNIFICANT DEVELOPMENTS IN DC-EXOSOME IMMUNOTHERAPY TO DRIVE MARKET GROWTH    103
9.4    OTHER MANUFACTURING SERVICES    103
10    EXOSOME RESEARCH MARKET, BY END USER    104
10.1    INTRODUCTION    105
TABLE 91    EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)    105
10.2    ACADEMIC & RESEARCH INSTITUTES    105
10.2.1    ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS IN
THE EXOSOME RESEARCH MARKET    105
TABLE 92    EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION)    106
TABLE 93    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)    106
TABLE 94    EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)    107
TABLE 95    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)    107
10.3    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES    107
10.3.1    SIGNIFICANT DEVELOPMENTS IN NANOMEDICINE TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT    107
TABLE 96    EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)    108
TABLE 97    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)    108
TABLE 98    EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)    108
TABLE 99    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)    109
10.4    HOSPITAL & CLINICAL TESTING LABORATORIES    109
10.4.1    INCREASE IN ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT    109
TABLE 100    EXOSOME RESEARCH MARKET FOR HOSPITAL & CLINICAL TESTING LABORATORIES, BY REGION, 2019–2026 (USD MILLION)    109
TABLE 101    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)    110
TABLE 102    EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)    110
TABLE 103    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)    110
11    EXOSOME RESEARCH MARKET, BY REGION    111
11.1    INTRODUCTION    112
TABLE 104    EXOSOME RESEARCH MARKET, BY REGION, 2019–2026 (USD MILLION)    112
11.2    NORTH AMERICA    113
FIGURE 22    NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT    113
TABLE 105    NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    114
TABLE 106    NORTH AMERICA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)    114
TABLE 107    NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)    114
TABLE 108    NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    115
TABLE 109    NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)    115
TABLE 110    NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    115
TABLE 111    NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    116
11.2.1    US    116
11.2.1.1    High burden of cancer and favorable public and private funding for research activities to drive market growth    116
FIGURE 23    US CONTINUES TO DOMINATE THE DISTRIBUTION OF R&D COMPANIES
BY REGION/COUNTRY (2021)    116
TABLE 112    US: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    117
TABLE 113    US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    117
TABLE 114    US: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    117
TABLE 115    US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    118
TABLE 116    US: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    118
TABLE 117    US: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    118
11.2.2    CANADA    119
11.2.2.1    Increasing funding for genome-based medical treatments to support market growth    119
TABLE 118    CANADA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    119
TABLE 119    CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    120
TABLE 120    CANADA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    120
TABLE 121    CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    120
TABLE 122    CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    121
TABLE 123    CANADA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    121
11.3    EUROPE    122
FIGURE 24    EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT    122
TABLE 124    EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    123
TABLE 125    EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    123
TABLE 126    EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    123
TABLE 127    EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    124
TABLE 128    EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    124
TABLE 129    EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    124
TABLE 130    EUROPE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    125
11.3.1    GERMANY    125
11.3.1.1    Strong academic research base bolsters market growth    125
TABLE 131    GERMANY: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    125
TABLE 132    GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)    126
TABLE 133    GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    126
TABLE 134    GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    126
TABLE 135    GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    127
TABLE 136    GERMANY: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    127
11.3.2    UK    127
11.3.2.1    Growth in the life sciences industry to drive the market for exosome research in the UK    127
TABLE 137    UK: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    128
TABLE 138    UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    128
TABLE 139    UK: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    128
TABLE 140    UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    129
TABLE 141    UK: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    129
TABLE 142    UK: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    129
11.3.3    FRANCE    130
11.3.3.1    Strong collaborative network between biotechnology entities and research institutes drives market growth    130
TABLE 143    FRANCE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    130
TABLE 144    FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    130
TABLE 145    FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    131
TABLE 146    FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    131
TABLE 147    FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    131
TABLE 148    FRANCE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    132
11.3.4    REST OF EUROPE    132
TABLE 149    ROE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    132
TABLE 150    ROE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    133
TABLE 151    ROE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    133
TABLE 152    ROE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    133
TABLE 153    ROE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    134
TABLE 154    ROE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    134
11.4    ASIA PACIFIC    135
TABLE 155    ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    135
TABLE 156    ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)    135
TABLE 157    ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)    136
TABLE 158    ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    136
TABLE 159    ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    136
TABLE 160    ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    137
TABLE 161    ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    137
11.4.1    CHINA    137
11.4.1.1    Government initiatives to strengthen the biotechnology industry and the high prevalence of cancer are major factors driving market growth    137
TABLE 162    CHINA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    138
TABLE 163    CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    138
TABLE 164    CHINA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    138
TABLE 165    CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    139
TABLE 166    CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    139
TABLE 167    CHINA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    139
11.4.2    JAPAN    140
11.4.2.1    High prevalence of cancer and increasing healthcare expenditure are the key drivers for the exosome research market in the country    140
TABLE 168    JAPAN: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    140
TABLE 169    JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    140
TABLE 170    JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    141
TABLE 171    JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    141
TABLE 172    JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    141
TABLE 173    JAPAN: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    142
11.4.3    REST OF ASIA PACIFIC    142
TABLE 174    ROAPAC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    142
TABLE 175    ROAPAC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    143
TABLE 176    ROAPAC: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    143
TABLE 177    ROAPAC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    143
TABLE 178    ROAPAC: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    144
TABLE 179    ROAPAC: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    144
11.5    REST OF THE WORLD    144
TABLE 180    ROW: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)    145
TABLE 181    ROW: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    145
TABLE 182    ROW: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)    145
TABLE 183    ROW: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)    146
TABLE 184    ROW: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    146
TABLE 185    ROW: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)    146
12    COMPETITIVE LANDSCAPE    147
12.1    INTRODUCTION    147
12.2    RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS    147
FIGURE 25    EXOSOME RESEARCH MARKET: STRATEGIES ADOPTED    147
12.3    MARKET SHARE ANALYSIS    148
FIGURE 26    EXOSOME RESEARCH MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)    148
12.4    COMPANY EVALUATION QUADRANT    150
12.4.1    STARS    150
12.4.2    EMERGING LEADERS    150
12.4.3    PERVASIVE PLAYERS    150
12.4.4    PARTICIPANTS    150
FIGURE 27    EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX, 2020 (TOP 10 PLAYERS)    151
12.5    COMPETITIVE BENCHMARKING    152
12.5.1    COMPANY SERVICE FOOTPRINT (10 COMPANIES)    152
FIGURE 28    SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET    152
12.6    COMPETITIVE SCENARIO AND TRENDS    153
12.6.1    DEALS (2016–2019)    153
TABLE 186    EXOSOME RESEARCH MARKET: DEALS    153
12.6.2    PRODUCT LAUNCHES (2016–2019)    154
TABLE 187    EXOSOME RESEARCH MARKET: PRODUCT LAUNCHES    154
12.6.3    OTHER DEVELOPMENTS (2016–2019)    154
TABLE 188    EXOSOME RESEARCH MARKET: OTHER DEVELOPMENTS    154
13    COMPANY PROFILES    155
13.1    KEY COMPANIES    155
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1    THERMO FISHER SCIENTIFIC, INC.    155
TABLE 189    THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW    155
FIGURE 29    THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT    156
TABLE 190    THERMO FISHER SCIENTIFIC, INC.: PRODUCT OFFERINGS    156
TABLE 191    THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS    157
13.1.2    SYSTEM BIOSCIENCES, LLC.    159
TABLE 192    SYSTEM BIOSCIENCES LLC: BUSINESS OVERVIEW    159
TABLE 193    SYSTEM BIOSCIENCES: PRODUCT & SERVICE OFFERINGS    159
TABLE 194    SYSTEM BIOSCIENCES LLC: DEALS    160
13.1.3    BIO-TECHNE    161
TABLE 195    BIO-TECHNE: BUSINESS OVERVIEW    161
FIGURE 30    BIO-TECHNE: COMPANY SNAPSHOT    162
TABLE 196    BIO-TECHNE: PRODUCT OFFERINGS    162
TABLE 197    BIO-TECHNE: PRODUCT LAUNCHES    163
TABLE 198    BIO-TECHNE: DEALS    163
13.1.4    QIAGEN    165
TABLE 199    QIAGEN: BUSINESS OVERVIEW    165
FIGURE 31    QIAGEN: COMPANY SNAPSHOT    166
TABLE 200    QIAGEN: PRODUCT OFFERINGS    166
TABLE 201    QIAGEN: DEALS    167
13.1.5    LONZA    169
TABLE 202    LONZA: BUSINESS OVERVIEW    169
FIGURE 32    LONZA: COMPANY SNAPSHOT    170
TABLE 203    LONZA: SERVICE OFFERINGS    170
TABLE 204    LONZA: DEALS    171
13.1.6    NX PHARMAGEN    172
TABLE 205    NX PHARMAGEN: BUSINESS OVERVIEW    172
TABLE 206    NX PHARMAGEN: SERVICE OFFERINGS    172
13.1.7    AMSBIO (AMS BIOTECHNOLOGY)    173
TABLE 207    AMSBIO: BUSINESS OVERVIEW    173
TABLE 208    AMSBIO: PRODUCT OFFERINGS    173
13.1.8    NANOSOMIX, INC.    174
TABLE 209    NANOSOMIX, INC.: BUSINESS OVERVIEW    174
TABLE 210    NANOSOMIX: PRODUCT OFFERINGS    174
13.1.9    MILTENYI BIOTEC    175
TABLE 211    MILTENYI BIOTEC: BUSINESS OVERVIEW    175
TABLE 212    MILTENYI BIOTEC: PRODUCT OFFERINGS    175
13.1.10    NORGEN BIOTEK CORP.    176
TABLE 213    NORGEN BIOTEK CORP.: BUSINESS OVERVIEW    176
TABLE 214    NORGEN BIOTEK: PRODUCT OFFERINGS    176
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2    OTHER PLAYERS    177
13.2.1    AETHLON MEDICAL, INC.    177
TABLE 215    AETHLON MEDICAL, INC.: COMPANY OVERVIEW    177
13.2.2    ANJARIUM BIOSCIENCES AG    177
TABLE 216    ANJARIUM BIOSCIENCES AG: COMPANY OVERVIEW    177
13.2.3    CILOA    178
TABLE 217    CILOA: COMPANY OVERVIEW    178
13.2.4    CLARA BIOTECH, INC.    178
TABLE 218    CLARA BIOTECH, INC.: COMPANY OVERVIEW    178
13.2.5    CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.    179
TABLE 219    CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.: COMPANY OVERVIEW    179
13.2.6    ILIAS BIOLOGICS, INC.    179
TABLE 220    ILIAS BIOLOGICS, INC.: COMPANY OVERVIEW    179
13.2.7    NANOVIEW BIOSCIENCES    180
TABLE 221    NANOVIEW BIOSCIENCES: COMPANY OVERVIEW    180
13.2.8    RION, LLC    180
TABLE 222    RION, LLC: COMPANY OVERVIEW    180
13.2.9    CELL GUIDANCE SYSTEMS LLC    181
TABLE 223    CELL GUIDANCE SYSTEMS: COMPANY OVERVIEW    181
13.2.10    INOVIQ (BARD1 LIFE SCIENCES LTD.)    181
TABLE 224    INOVIQ: COMPANY OVERVIEW    181
13.2.11    NOVUS BIOLOGICALS    182
TABLE 225    NOVUS BIOLOGICALS: COMPANY OVERVIEW    182
13.2.12    BIOVISION INC.    182
TABLE 226    BIOVISION INC.: COMPANY OVERVIEW    182
13.2.13    PALL CORPORATION    183
TABLE 227    PALL CORPORATION: COMPANY OVERVIEW    183
13.2.14    EXOPHARM    183
TABLE 228    EXOPHARM: COMPANY OVERVIEW    183
13.2.15    EVERZOM    184
TABLE 229    EVERZOM: COMPANY OVERVIEW    184
14    APPENDIX    185
14.1    DISCUSSION GUIDE    185
14.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    188
14.3    AVAILABLE CUSTOMIZATIONS    190
14.4    RELATED REPORT    190
14.5    AUTHOR DETAILS    191"